Search

Junning X Lee

from Encinitas, CA
Age ~68
Get Report
Also known as:
Junning Ee, Xiaojun Lee Junning, Lee Junning
Related to:
Lisa D Roman, 58Marsha Doniger, 78Inil Lee, 66Michelle Mullin, 43Jung LeeHyun U Lee, 40
Connected to:
Aarron Lee, 39Ada P Lee, 66Adam Y Lee, 63Adrienna V Lee, 57Aekyung P Lee, 66Aeron C Lee, 48Ahmed F Lee, 57Ahran Lee, 38Ahrom A Lee, 37Aiesha M Lee, 40

Junning Lee Phones & Addresses

  • Encinitas, CA
  • Half Moon Bay, CA
  • Hillsborough, CA
  • El Granada, CA
  • 503 Meyersville Rd, Gillette, NJ 07933 (908) 604-8385 (908) 604-9401
  • South San Francisco, CA
  • San Mateo, CA
  • Springfield, NJ

Publications

Us Patents

8-Chloro-6,11-Dihydro-11-(4-Piperidylidine)-5H-Benzo[5,6]Cyclohepta[1-2-B] Pyridine

View page
US Patent:
6506767, Jan 14, 2003
Filed:
Jul 1, 1998
Appl. No.:
09/108689
Inventors:
Doris P. Schumacher - Bedminster NJ
Junning Lee - Gillette NJ
Lawrence R. Rogers - Short Hills NJ
Charles G. Eckhart - Scotch Plains NJ
Naneshwar S. Sawant - Edison NJ
Michael B. Mitchell - Basking Ridge NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D40108
US Classification:
514290, 546 93
Abstract:
Crystalline polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cycloheptic[1,2-b]pyridine represented by the formula pharmaceutical compositions containing such polymorphs, and methods of using such polymorphs to treat allergic reactions in mammals such as man are disclosed.

Process For Preparing N-Protected Β-Amino Aldehyde Compounds

View page
US Patent:
6951963, Oct 4, 2005
Filed:
Jun 16, 2003
Appl. No.:
10/462150
Inventors:
Junning Lee - El Granada CA, US
Jyanwei Liu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07D307/00
US Classification:
568306, 568307
Abstract:
The invention provides processes for preparing N-protected β-amino aldehyde compounds which are useful as synthetic intermediates for preparing glycopeptide antibiotic derivatives. The processes include cleaving a carbon-carbon double bond to form the N-protected β-amino aldehyde compound.

Process For Preparing Glycopeptide Phosphonate Derivatives

View page
US Patent:
6979723, Dec 27, 2005
Filed:
Aug 23, 2002
Appl. No.:
10/226428
Inventors:
Michael R. Leadbetter - San Leandro CA, US
Martin S. Linsell - San Mateo CA, US
Junning Lee - El Granada CA, US
Jyanwei Liu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
A61K038/00
US Classification:
530322
Abstract:
Disclosed are processes for preparing glycopeptide phosphonate derivatives having an amino-containing side chain. Several of the process steps are conducted in a single reaction vessel without isolation of intermediate reaction products, thereby generating less waste and improving the overall efficiency and yield of the process.

Process For Preparing Glycopeptide Derivatives

View page
US Patent:
7015305, Mar 21, 2006
Filed:
Aug 23, 2002
Appl. No.:
10/226988
Inventors:
Junning Lee - El Granada CA, US
Jyanwei Liu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
A61K 38/00
US Classification:
530317, 514 18
Abstract:
Disclosed are processes for preparing glycopeptide antibiotic derivatives having an amino-containing side chain. The multi-step process is conducted in a single reaction vessel without isolation of intermediate reaction products.

Process For Preparing Glycopeptide Derivatives

View page
US Patent:
7160984, Jan 9, 2007
Filed:
Nov 8, 2005
Appl. No.:
11/268913
Inventors:
Junning Lee - El Granada CA, US
Jyanwei Liu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
A61K 38/12
A61K 38/00
US Classification:
530317, 514 2, 514 9
Abstract:
Disclosed are processes for preparing glycopeptide antibiotic derivatives having an amino-containing side chain. The multi-step process is conducted in a single reaction vessel without isolation of intermediate reaction products.

Process For Preparing Glycopeptide Phosphonate Derivatives

View page
US Patent:
7301004, Nov 27, 2007
Filed:
May 19, 2006
Appl. No.:
11/437066
Inventors:
Michael R. Leadbetter - San Leandro CA, US
Martin S. Linsell - San Mateo CA, US
Junning Lee - El Granada CA, US
Jyanwei Liu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
A61K 38/14
C07K 9/0014
US Classification:
530322
Abstract:
Disclosed are processes for preparing glycopeptide phosphonate derivatives having an amino-containing side chain. Several of the process steps are conducted in a single reaction vessel without isolation of intermediate reaction products, thereby generating less waste and improving the overall efficiency and yield of the process.

Crystalline Form Of A Biphenyl Compound

View page
US Patent:
7320990, Jan 22, 2008
Filed:
Feb 11, 2005
Appl. No.:
11/057009
Inventors:
Robert Chao - Santa Clara CA, US
Miroslav Rapta - Sunnyvale CA, US
Pierre-Jean Colson - San Francisco CA, US
Junning Lee - El Granada CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07D 211/56
C07D 211/72
A61K 31/47
US Classification:
514317, 546224, 546304, 546312
Abstract:
The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of biphenyl-2-ylcarbamic acid 1-{9-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro-quinolin-5 -yl)ethylamino]nonyl}piperidin-4-yl ester or a solvate thereof. This invention also provides pharmaceutical compositions comprising such a salt or prepared using such a salt; processes and intermediates for preparing such a salt; and methods of using such a salt to treat a pulmonary disorder.

Hydrochloride Salts Of A Glycopeptide Phosphonate Derivative

View page
US Patent:
7531623, May 12, 2009
Filed:
Oct 21, 2004
Appl. No.:
10/970128
Inventors:
Jyanwei Liu - Sunnyvale CA, US
Junning Lee - El Granada CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07K 7/56
US Classification:
530317
Abstract:
Disclosed are hydrochloride salts of telavancin having a chloride ion content of from about 2. 4 wt. % to about 4. 8 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts. Also disclosed are processes for preparing such salts.
Control profile
Junning X Lee from Encinitas, CA, age ~68 Get Report